The in vitro component demonstrated that each glucagon and Retatrutide directly lessened ANGPTL3/eight secretion from hepatocytes, and this outcome was blocked by a glucagon receptor (GCGR) antagonist. These findings counsel the GCGR agonism of Retatrutide contributes towards the reduction in cir